Julia is a senior associate at Atlas Venture where she focuses on investing in and building companies that develop novel therapies to improve patients’ lives. Julia serves as a board observer for nChroma Bio, Pheon Therapeutics, Renasant Bio, and a stealth newco. She was previously a board observer at Sionna Therapeutics (NASDAQ:SION).

Prior to joining Atlas, she completed her residency in pediatrics at Boston Children’s Hospital and Boston Medical Center. Julia continues to practice medicine as a pediatric hospitalist at Boston Medical Center.

Prior to joining Atlas, Julia completed her residency in pediatrics at Boston Children’s Hospital and Boston Medical Center. She continues to practice medicine as a pediatric hospitalist at Boston Medical Center. Julia also leads the Access Working Group of the N-of-1 Collaborative.

She earned her AB in chemical and physical biology summa cum laude from Harvard College with a secondary field in English, her MD from Harvard Medical School, and her MBA from Harvard Business School with honors. A black-belt in taekwondo, Julia has won multiple World Championship titles and co-founded a martial arts school for kids. In her free time, she is a theater aficionado, Formula 1 fan, and amateur culinary enthusiast.